NCT00075855 - Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

October 31, 2007

Conditions

Cancer SurvivorSexual DysfunctionSexuality and Reproductive IssuesUnspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

therapeutic testosterone

OTHER

placebo

Trial Locations (16)

32224

Mayo Clinic - Jacksonville, Jacksonville

45429

CCOP - Dayton, Dayton

48106

CCOP - Michigan Cancer Research Consortium, Ann Arbor

54301

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay

55905

Mayo Clinic Cancer Center, Rochester

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

58122

CCOP - Merit Care Hospital, Fargo

61801

CCOP - Carle Cancer Center, Urbana

68106

CCOP - Missouri Valley Cancer Consortium, Omaha

85259-5404

CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

58501-5505

Medcenter One Health System, Bismarck

17822-2001

CCOP - Geisinger Clinic and Medical Center, Danville

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER